October 4-5, 2019
New York, NY
Innovations in imaging technologies, research studies, and surgical techniques have improved the outcomes associated with diagnosis and treatment of pediatric and adult patients with congenital heart disorders. The complexity of the pathophysiology and innovative nature of the technologies and techniques, however, have created gaps among practitioners regarding their knowledge of the advances and their implications for clinical practice. This activity is designed to improve participants’ competence and skills to diagnose and select appropriate treatment strategies for this population.
After completing this activity, the participant will be able to do the following:
Detail the pathophysiology of hypoplastic left heart syndrome, describe imaging technologies, and summarize recent innovations in surgical approaches for treating this patient population.
Apply recent innovations in imaging and surgery to diagnose and treat patients with complicated congenital heart dysfunctions.
Critically appraise outcomes data on management approaches to congenital heart disease and describe their potential implications for clinical practice.
Utilize advancements in 3-D printing technology to assess the anatomy and pathophysiology of complex congenital heart defects.
Detail advances in surgical, medical, and perioperative strategies for managing pediatric patients with complex congenital heart disease and assess their best use in clinical practice.
Describe state-of-the-art surgical approaches to preserving and restoring valvular function in both pediatric and adult patients.
Present an evidence-based debate of the medical and surgical options for managing adults with congenital heart disease, specifically right ventricular dysfunction with tetralogy, atrial arrhythmias, and coarctation and hypertension.
Cardiologists, internal medicine, pediatricians, cardiovascular surgeons, nurses, physician assistants, and all health care providers involved in the care of patients with congenital heart disease.